NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-232-2004-2-IN-09 DNA expression vectors and methods of use IN National Stage IN/PCT/2002/01197 Expired
NIDDK E-109-2001-0-US-03 Methods for Improving the Function of Heterogolous Protein-Coupled Receptors US National Stage 09/786,033 7094593 Abandoned PDF
CC E-278-1999-0-PCT-02 Multiplex Hybridization System for the Identification of Pathogenic Mycobacterium and Method of Use PCT PCT PCT/US01/06731 Abandoned
NIDCR E-131-1999-0-PCT-02 Methods for Wound Treatment PCT PCT PCT/US01/06675 Abandoned
CC E-278-1999-0-EP-03 Multiplex Hybridization System For Identification Of Pathogenic Mycobacterium And Method Of Use EP National Stage 01913255.4 Abandoned
NCI E-331-2000-0-US-02 DNA Encoding a Growth Factor Specific for Epithelial Cells US REISSUE 09/795,702 Abandoned
NHLBI E-003-2000-0-PCT-02 Regulators of Type-1 Tumor Necrosis Factor Receptor and Other Cytokine Receptor Shedding PCT PCT PCT/US01/06464 Expired
NIEHS E-080-1994-0-US-03 DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1 US DIV 09/795,380 6756201 Abandoned PDF
NCI E-282-2000-0-US-01 Analogs of Thalidomide as Potential Angiogenesis Inhibitors US 60/271,941 Abandoned
NCI E-143-1998-0-US-04 Nucleic Acids Comprising a Post-Transcriptional Regulatory Elements (PRE) and Their Uses US National Stage 09/673,716 6919442 Abandoned PDF
NIA E-180-1992-0-US-12 TARGETING OF LIPOSOMES TO THE BLOOD-BRAIN BARRIER US CON 09/794,719 Abandoned
NCI E-077-2001-0-US-01 Enhanced Homologous Recombination Mediated By Lambda Recombination Protein US 60/271,632 Abandoned
NCI E-009-2000-0-CA-06 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof CA National Stage 2400868 Abandoned
NCI E-009-2000-0-EP-03 Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof EP National Stage 01914471.6 Expired
NCI E-009-2000-0-GB-27 Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof GB EP 01914471.6 Abandoned
NCI E-009-2000-0-DE-25 Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof DE EP 01914471.6 Abandoned
NCI E-009-2000-0-FR-26 Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof FR EP 01914471.6 Abandoned
NCI E-009-2000-0-KR-10 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof KR National Stage 2002-7011187 Abandoned
NCI E-009-2000-0-RU-08 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof RU National Stage 2002125514 Abandoned
NCI E-009-2000-0-UA-19 Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof UA National Stage 2002086976M Abandoned
NCI E-009-2000-0-AU-05 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof AU National Stage 2001239857 Abandoned
NCI E-009-2000-0-PCT-02 Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof PCT PCT PCT/US2001/005923 Expired
NIAID E-171-1986-1-US-06 PERTUSSIS TOXIN GENE: CLONING AND EXPRESSION OF PROTECTIVE ANTIGEN US CON 09/792,861 Abandoned
NCI E-009-2000-0-JP-04 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof JP National Stage 2001-562705 Abandoned
NCI E-009-2000-0-HU-17 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof HU National Stage P0204142 Abandoned
NCI E-009-2000-0-CZ-16 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof CZ National Stage 2002-2796 Abandoned
NCI E-009-2000-0-MX-11 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof MX National Stage PA/a/2002/008178 Abandoned
NCI E-009-2000-0-NO-12 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof NO National Stage 2002 4034 Abandoned
NCI E-009-2000-0-PL-07 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof PL National Stage P357448 Abandoned
NCI E-009-2000-0-SK-22 Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof SK National Stage 1223-2002 Abandoned
NCI E-009-2000-0-BG-18 Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof BG National Stage 106998 Abandoned
NCI E-009-2000-0-BR-14 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof BR National Stage PI0108646-4 Abandoned
NCI E-009-2000-0-BA-23 Anti-EGFRvIII scFvs With Improved Cytotoxicity and Yield, Immunotoxin Based Thereon, and Methods of Use Thereof BA National Stage BAP021207A Abandoned
NCI E-009-2000-0-YU-09 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof YU National Stage P-633/02 Abandoned
NIMH E-184-1998-0-US-02 DNA Sequence Surrounding the Glucocerebrosidase Gene US CON 09/790,852 Abandoned
NIDCD E-228-1995-1-US-02 CONJUGATE VACCINE FOR NONTYPEABLE HAEMOPHILUS INFLUENZAE US DIV 09/789,017 6607725 Expired PDF
NCI E-058-2003-0-US-01 Generation Of Biomaterial Microarrays By Laser Transfer US 60/269,364 Abandoned
NCI E-099-2001-0-US-01 Mitochondrial Topoisomerase 1 US 60/269,496 Abandoned
NHLBI E-082-2001-0-US-01 Real-Time, Interactive Volumetric Magnetic Resonance Imaging US 60/269,363 Abandoned
NINDS E-082-1997-0-US-03 USE OF MARROW-DERIVED GLIAL PROGENITORS CELLS AS GENE DELIVERY VECHICLES INTO THE CENTRAL NERVOUS SYSTEM US CON 09/819,096 Abandoned
NCI E-122-2000-0-US-02 Flavopiridol Methods and Compositions for HIV Therapy US National Stage 09/784,633 6660750 Abandoned PDF
NCI E-122-2000-0-PCT-03 Compositions Comprising Flavopiridol And Their Use For HIV Therapy PCT PCT PCT/US01/04898 Abandoned
CC E-239-2001-0-US-01 Vessel Surface Reconstruction With A Tubular Deformable Model Vessel US 60/269,159 Abandoned
NCI E-190-2000-0-US-01 Methods and Compositions For Inhibiting HIV-Coreceptor Interactions US 60/269,534 Abandoned
NCI E-047-2000-2-PCT-01 cDNA Encoding a TRAG (TGF-Beta Resistance Associated Gene) and its Protein Product (As filed) PCT PCT COMB PCT/US2001/004475 Abandoned
NCI E-260-1999-0-PCT-02 Method for Refolding Recombinant Endostatin PCT PCT PCT/US01/004547 Expired
NCI E-314-2001-0-US-01 Nucleic Acids of The Human ABCA12 Gene, Vectors Containing Such Nucleic Acids And Uses Thereof US 60/267,715 Abandoned
NIAID E-281-1998-0-IN-10 Full-Length Infectious cDNA Clones Of Tick Borne Flavivirus IN DIV 9396/DELNP/2007 Abandoned
NIAID E-281-1998-0-CN-17 Full-Length Infectious cDNA Clones Of Tick Borne Flaviviruse CN DIV 200810131870.7 Abandoned
NCI E-254-1999-0-US-06 Tumor Suppressor Gene, p47ING3 US DIV 13/271,026 8415097 Abandoned PDF